⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CMPX News
Compass Therapeutics, Inc. Common Stock
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
CMPX
Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
globenewswire.com
CMPX
Compass Therapeutics to Participate in Upcoming November Investor Events
globenewswire.com
CMPX